Hormonal therapy for metastatic cancer
- Luprolide (Lupron) 7.5 mg sc qm or 22.5 mg sc q3m
- Trade Name: Lupron
- Lupron is a hormone therapy. It is classified as an "LHRH agonist."
- Prostate cancer
- Breast, ovarian and endometrial cancer
- Also used in non-cancerous conditions such as endometriosis, infertility, benign prostatic hypertrophy (BPH).
Loblaw DA et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 2007; 25:1596